MYBPC3 and cardiac hypertrophy: Finally, 1-day-old homozygous Mybpc3-targeted knock-in mice treated with AAV9–Mybpc3 demonstrated increased total protein levels of myosin binding protein C (MyBP-C) and prevention of cardiac hypertrophy development (67).